Remogliflozin etabonate
Remogliflozin etabonate is an antidiabetic drug in the SGLT2 inhibitors class. It was developed by BHV Pharma and is currently marketed in India by Glenmark Pharmaceuticals under the brand name Sugalpha ER.
Medical uses[edit | edit source]
Remogliflozin etabonate is used in the treatment of Type 2 diabetes. It works by inhibiting the SGLT2 protein, which is involved in glucose reabsorption in the kidneys. This leads to an increase in glucose excretion and a decrease in blood glucose levels.
Side effects[edit | edit source]
The most common side effects of remogliflozin etabonate include urinary tract infections, genital infections, and increased urination. Less common side effects may include low blood pressure, ketoacidosis, and kidney injury.
Pharmacology[edit | edit source]
Remogliflozin etabonate is a prodrug that is metabolized in the body to its active form, remogliflozin. It inhibits the SGLT2 protein in the proximal tubules of the kidneys, leading to an increase in glucose excretion and a decrease in blood glucose levels.
History[edit | edit source]
Remogliflozin etabonate was developed by BHV Pharma and is currently marketed in India by Glenmark Pharmaceuticals. It was approved for use in India in April 2019.
See also[edit | edit source]
| Remogliflozin etabonate Resources | |
|---|---|
|
 |
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
